1. Home
  2. BDTX vs MSGY Comparison

BDTX vs MSGY Comparison

Compare BDTX & MSGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • MSGY
  • Stock Information
  • Founded
  • BDTX 2014
  • MSGY 2018
  • Country
  • BDTX United States
  • MSGY Hong Kong
  • Employees
  • BDTX N/A
  • MSGY N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MSGY
  • Sector
  • BDTX Health Care
  • MSGY
  • Exchange
  • BDTX Nasdaq
  • MSGY Nasdaq
  • Market Cap
  • BDTX 181.4M
  • MSGY 186.3M
  • IPO Year
  • BDTX 2020
  • MSGY 2025
  • Fundamental
  • Price
  • BDTX $3.99
  • MSGY $1.52
  • Analyst Decision
  • BDTX Strong Buy
  • MSGY
  • Analyst Count
  • BDTX 5
  • MSGY 0
  • Target Price
  • BDTX $12.00
  • MSGY N/A
  • AVG Volume (30 Days)
  • BDTX 1.0M
  • MSGY 852.3K
  • Earning Date
  • BDTX 11-04-2025
  • MSGY 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • MSGY N/A
  • EPS Growth
  • BDTX N/A
  • MSGY N/A
  • EPS
  • BDTX 0.25
  • MSGY 0.10
  • Revenue
  • BDTX $70,000,000.00
  • MSGY $23,318,482.00
  • Revenue This Year
  • BDTX N/A
  • MSGY N/A
  • Revenue Next Year
  • BDTX N/A
  • MSGY N/A
  • P/E Ratio
  • BDTX $15.96
  • MSGY $15.51
  • Revenue Growth
  • BDTX N/A
  • MSGY 13.04
  • 52 Week Low
  • BDTX $1.20
  • MSGY $1.41
  • 52 Week High
  • BDTX $4.10
  • MSGY $22.20
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 69.63
  • MSGY N/A
  • Support Level
  • BDTX $3.81
  • MSGY N/A
  • Resistance Level
  • BDTX $4.03
  • MSGY N/A
  • Average True Range (ATR)
  • BDTX 0.20
  • MSGY 0.00
  • MACD
  • BDTX 0.04
  • MSGY 0.00
  • Stochastic Oscillator
  • BDTX 91.58
  • MSGY 0.00

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About MSGY Masonglory Limited Ordinary Shares

Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.

Share on Social Networks: